Showing results (21-30 of 272) with videos related to
Sort By:
Pageof 28
Clinical Genitourinary Cancer|May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinomaKevin A David, Matthew I Milowsky, David M NanusThe Oncologist|July 26, 2013
Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancerDavid D Chism, Michael E Woods, Matthew I MilowskyCurrent Opinion in Urology|March 12, 2019
Perioperative systemic therapy for bladder cancerPatrick J Eulitt, Marc A Bjurlin, Matthew I MilowskyCancer|October 15, 2013
Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006Matthew E Nielsen, Angela B Smith, Anne-Marie Meyer, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 22, 2020
Bladder preservation in muscle-invasive bladder cancer: a comprehensive reviewJudy Hamad, Hannah McCloskey, Matthew I Milowsky, et al.JCI Insight|October 5, 2016
Claudin-low bladder tumors are immune infiltrated and actively immune suppressedJordan Kardos, Shengjie Chai, Lisle E Mose, et al.ACS Nano|September 27, 2016
The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type TumorsLei Miao, Jay M Newby, C Michael Lin, et al.BJU International|April 1, 2018
Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancerYair Lotan, Solomon L Woldu, Oner Sanli, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biologyJeffrey S Damrauer, Katherine A Hoadley, David D Chism, et al.Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.Pageof 28